Copyright © 2001 by the European Society of Cardiology.
Editorial
Quality of life in atrial fibrillation: relevance of the autonomic nervous system
University of Bonn, Bonn, Germany
References
- Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Stat Med. 1991;10:19151930[Web of Science][Medline]
- van den Berg MP, Hassink RJ, Tuinenburg AE. Quality of life in patients with paroxysmal atrial fibrillation and its predictors. Importance of the autonomic nervous system. Eur Heart J. 2001;22:247253
[Abstract/Free Full Text] - Lüderitz B, Jung W. Quality of life in patients with atrial fibrillation. Arch Intern Med. 2000;160:17491757
[Abstract/Free Full Text] - Dorian P, Jung W, Newman D. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000;36:13031309
[Abstract/Free Full Text] - Reiffel JA. Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision. Am J Cardiol. 1998;82:72N81N[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
J. C. Pruitt, R. R. Lazzara, G. H. Dworkin, V. Badhwar, C. Kuma, and G. Ebra Totally Endoscopic Ablation of Lone Atrial Fibrillation: Initial Clinical Experience Ann. Thorac. Surg., April 1, 2006; 81(4): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
